Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Regulation of BOB.1/OBF.1 stability by SIAH.

J Boehm1, Y He, A Greiner

  • 1Institut für Medizinische Strahlenkunde und Zellforschung (MSZ), Universität Würzburg, Versbacher Strasse 5, 97078 Würzburg, Germany.

The EMBO Journal
|August 3, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RFC1-related disorders: A case series of 4-aminopyridine and acetyl-DL-leucine treatment.

Cerebellum (London, England)·2026
Same author

Training in movement disorders during neurology residency in France: A national survey on educational gaps and future perspectives.

Revue neurologique·2025
Same author

Supplementary orthopaedic screening for children and adolescents to prevent permanent skeletal deformities - protocol for the "OrthoKids" study.

BMC musculoskeletal disorders·2023
Same author

Radial head distalisation with an external ring fixator as a therapy option in children with chronic posttraumatic radiocapitellar dislocations.

European journal of trauma and emergency surgery : official publication of the European Trauma Society·2022
Same author

Disruption of striatal dopaminergic pathway: A new plot twist in dystonia genetic story.

Revue neurologique·2022
Same author

Early hyperdopaminergic state following sub-thalamic nucleus deep brain stimulation in Parkinson disease.

Revue neurologique·2022

The BOB.1/OBF.1 coactivator is crucial for B lymphocyte function and germinal center formation. Its protein levels are regulated by SIAH1 and SIAH2, which promote degradation, impacting B-cell receptor signaling.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • The BOB.1/OBF.1 coactivator is essential for octamer-dependent transcription in B lymphocytes.
  • Mice lacking BOB.1/OBF.1 exhibit defects in B-cell development, including absent germinal centers.
  • BOB.1/OBF.1 levels are significantly higher in germinal center B cells than in resting B cells.

Purpose of the Study:

  • To investigate the post-transcriptional mechanisms regulating BOB.1/OBF.1 protein levels.
  • To identify proteins that interact with BOB.1/OBF.1 and influence its stability.
  • To elucidate the role of protein degradation pathways in controlling BOB.1/OBF.1 function.

Main Methods:

  • Yeast two-hybrid screening to identify BOB.1/OBF.1 interacting proteins.
  • Cotransfection experiments to assess the effect of SIAH1 and SIAH2 on BOB.1/OBF.1 stability.

Related Experiment Videos

  • Treatment with proteasome inhibitors to block protein degradation.
  • B-cell receptor cross-linking assays to study signaling-induced protein turnover.

    • Main Results:

    • SIAH1 and SIAH2 were identified as BOB.1/OBF.1 interacting proteins.
    • Coexpression of SIAH proteins led to decreased BOB.1/OBF.1 protein levels without affecting mRNA.
    • Proteasome inhibitors prevented BOB.1/OBF.1 degradation.
    • B-cell receptor cross-linking induced BOB.1/OBF.1 degradation.

    Conclusions:

    • BOB.1/OBF.1 protein stability is regulated by SIAH1 and SIAH2 via proteasomal degradation.
    • B-cell receptor signaling triggers BOB.1/OBF.1 degradation, modulating transcriptional activity.
    • These findings reveal a novel regulatory mechanism for BOB.1/OBF.1 impacting B-cell function.